Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clareon TruPlus Study

NCT: NCT07502456 · NOT_YET_RECRUITING

NCT IDNCT07502456
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2028-06

Brief Summary

The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.

Frequently Asked Questions

What is Clareon TruPlus Study?

Clareon TruPlus Study is a clinical trial registered under NCT07502456. Current status: NOT_YET_RECRUITING.

What is the status of NCT07502456?

The current status of NCT07502456 (Clareon TruPlus Study) is: NOT_YET_RECRUITING.

When did Clareon TruPlus Study start?

Clareon TruPlus Study started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑